Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 77.00 | |
25 mg | In stock | $ 172.00 | |
50 mg | In stock | $ 293.00 | |
100 mg | In stock | $ 513.00 | |
500 mg | In stock | $ 1,090.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases. |
In vitro | BML-259 prevents a large population of cells from NAC-evoked cell death[1]. |
Synonyms | CAY10554 |
Molecular Weight | 260.35 |
Formula | C14H16N2OS |
CAS No. | 267654-00-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO:PBS (pH 7.2)(1:2): 0.3 mg/mL
DMF: 30 mg/mL
DMSO: 120 mg/mL (460.92 mM), Sonication is recommended.
Ethanol: 0.25 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BML-259 267654-00-2 Cell Cycle/Checkpoint CDK protein CAY 10554 p53 CAY10554 death disease,neurotoxicity cell Inhibitor inhibit BML 259 Cyclin dependent kinase CAY-10554 Alzheimer's BML259 inhibitor